Table 2

Exposure to the different biologic response modifiers depending on diagnosis in BIOBADASER

Diagnosis

Infliximab

Etanercept

Adalimumab

Rheumatoid arthritis

5,521 (840)

1,724 (188)

526 (67)

All spondylarthritis

1,915 (211)

507 (35)

5.7 (3)

Ankylosing spondylitis

873 (87)

134 (13)

0.8 (0)

Psoriatic arthritis

636 (84)

325 (16)

2.6 (2)

Undifferentiated spondylarthritis

257 (28)

35 (4)

1.4 (0)

Crohn's related spondylarthritis

124 (9)

2.8 (0)

0.7 (0)

Other spondylarthritis

22 (3)

9.5 (2)

0.3 (1)

Numbers indicate total patient-years. In parentheses are the numbers of treatments discontinued.

Carmona et al. Arthritis Research & Therapy 2006 8:R72   doi:10.1186/ar1941